share_log

康寧傑瑞製藥-B：截至二零二四年二月二十九日止月份之股份發行人的證券變動月報表

ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

香港交易所 ·  Mar 5 06:00
Summary by Moomoo AI
康宁杰瑞制药-B（09966.HK）於2024年2月29日提交了最新的證券變動月報表。報告顯示，截至2024年2月底，公司的法定/註冊股本總額維持在50,200美元，普通股數目保持在25,100,000,000股，未發生變動。已發行股份數目同樣維持在964,843,807股。股份期權方面，根據首次公開發售前購股權計劃一，本月底結存的股份期權數目為21,425,655股，相較上月減少140,545股。首次公開發售前購股權計劃二的股份期權數目減少210,810股至5,036,585股。首次公開發售後購股權計劃則無變動，結存股份期權數目為1,924,000股。本月內沒有因行使期權而得到的資金。報告由執行董事徐霆於2024年3月5日呈交，並確認所有證券變動均符合香港聯合交易所有限公司證券上市規則的要求。
康宁杰瑞制药-B（09966.HK）於2024年2月29日提交了最新的證券變動月報表。報告顯示，截至2024年2月底，公司的法定/註冊股本總額維持在50,200美元，普通股數目保持在25,100,000,000股，未發生變動。已發行股份數目同樣維持在964,843,807股。股份期權方面，根據首次公開發售前購股權計劃一，本月底結存的股份期權數目為21,425,655股，相較上月減少140,545股。首次公開發售前購股權計劃二的股份期權數目減少210,810股至5,036,585股。首次公開發售後購股權計劃則無變動，結存股份期權數目為1,924,000股。本月內沒有因行使期權而得到的資金。報告由執行董事徐霆於2024年3月5日呈交，並確認所有證券變動均符合香港聯合交易所有限公司證券上市規則的要求。
Conning Jerry Pharmaceutical-B (09966.HK) filed its latest Securities Monthly Change Report on February 29, 2024. The report shows that as of the end of February 2024, the total authorized/registered share capital of the company remained at $50,200 and the number of ordinary shares remained at 25,100,000,000 shares, unchanged. The number of issued shares remained the same at 964,843,807 shares. In terms of stock options, the number of stock options outstanding at the end of the month under Initial Public Offering Plan 1 was 21,425,655 shares, a decrease of 140,545 shares compared to the previous month. The number of stock options under the Initial Public Offering Option Plan 2 decreased by 210,810 shares to 5,036,585 shares. The share option plan after the initial public offering was unchanged, with 1,924,000 shares outstanding. No funds received during the month due to exercise options. The report was submitted by Executive Director Xu Ting on 5 March 2024 and confirmed that all changes in securities comply with the requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Conning Jerry Pharmaceutical-B (09966.HK) filed its latest Securities Monthly Change Report on February 29, 2024. The report shows that as of the end of February 2024, the total authorized/registered share capital of the company remained at $50,200 and the number of ordinary shares remained at 25,100,000,000 shares, unchanged. The number of issued shares remained the same at 964,843,807 shares. In terms of stock options, the number of stock options outstanding at the end of the month under Initial Public Offering Plan 1 was 21,425,655 shares, a decrease of 140,545 shares compared to the previous month. The number of stock options under the Initial Public Offering Option Plan 2 decreased by 210,810 shares to 5,036,585 shares. The share option plan after the initial public offering was unchanged, with 1,924,000 shares outstanding. No funds received during the month due to exercise options. The report was submitted by Executive Director Xu Ting on 5 March 2024 and confirmed that all changes in securities comply with the requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more